title: Does intraabdominal use of Ankaferd Blood Stopper cause increased intraperitoneal adhesions?
authors.affiliation: Department of General Surgery, Zonguldak Karaelmas University, Faculty of Medicine, Zonguldak, Turkey.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Cömert
authors.forename: Kemal
authors.initials: K
authors.lastname: Karakaya
authors.forename: Figen
authors.initials: F
authors.lastname: Barut
authors.forename: Güldeniz
authors.initials: G
authors.lastname: Karadeniz Çakmak
authors.forename: Hamdi Bülent
authors.initials: HB
authors.lastname: Uçan
authors.forename: Fatma Ayça
authors.initials: FA
authors.lastname: Gültekin
authors.forename: Ali Uğur
authors.initials: AU
authors.lastname: Emre
authors.forename: Oge
authors.initials: O
authors.lastname: Taşçılar
authors.forename: Oktay
authors.initials: O
authors.lastname: Irkörücü
authors.forename: Handan
authors.initials: H
authors.lastname: Ankaralı
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D010532:Peritoneal Diseases / Q000209:etiology*; D010936:Plant Extracts / Q000009:adverse effects*; D051381:Rats; D011920:Rats, Inbred WF; D000267:Tissue Adhesions / Q000517:prevention & control*
chemical_list: D010936:Plant Extracts; C539751:ankaferd blood stopper